NOXCOVID is now listed on clinicaltrials.gov
See: https://clinicaltrials.gov/ct2/show/NCT04555213?term=NOX66&cond=COVID-19&draw=2&rank=1
This listing gives a snapshot of the trial, which will be conducted in accordance with a full (unpublished) study protocol. More detail will typically be added in due course.
40 patients, starts with dose escalation (400/600/800/1200/1800 mg) to confirm maximum tolerated dose, then dose expansion at recommended Part 2 dose. NOX had previously announced that patients will be treated for 14 days, so the response of each cohort should quickly become evident. We will need to be immediately informed if there are serious adverse events, so silence is a good sign!
Protocol
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.010(9.52%) |
Mkt cap ! $33.60M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 14.0¢ | 11.0¢ | $559.0K | 4.481M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6612 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 99714 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| NOX (ASX) Chart |